Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral acetaminophen versus oral ibuprofen for patent ductus arteriosus in preterm neonates
IRCT20211010052715N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in patent ductus arteriosus (PDA) comparing Oral acetaminophen with Oral ibuprofen (2 arms). Primary endpoint: Closure of the ductus arteriosus. Started Apr 2021; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20211010052715N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211010052715N1.